These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4182)

  • 61. The influence of intrinsic sympathomimetic activity and beta-1 receptor selectivity on the recovery of finger skin temperature after finger cooling in normotensive subjects.
    Lenders JW; Salemans J; de Boo T; Lemmens WA; Thien T; van't Laar A
    Clin Pharmacol Ther; 1986 Mar; 39(3):353-7. PubMed ID: 2868824
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
    Sal'nikov EV
    Bull Exp Biol Med; 2009 Feb; 147(2):181-4. PubMed ID: 19513416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
    Rascher W; Mann JF; Schömig A; Dietz R; Lüth JB
    Klin Wochenschr; 1978; 56 Suppl 1():87-90. PubMed ID: 32434
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1971 Sep; 43(1):222-35. PubMed ID: 4400184
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of beta blockade with and without sympathomimetic activity (ISA) on sympathovagal balance and baroreflex sensitivity.
    Haberthür C; Schächinger H; Langewitz W; Ritz R
    Clin Physiol; 1999 Mar; 19(2):143-52. PubMed ID: 10200896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
    Simon G; Wittig VJ
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration.
    Gugler R; Krist R; Raczinski H; Höffgen K; Boden G
    Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486
    [No Abstract]   [Full Text] [Related]  

  • 68. Beta-adrenergic blockade and atrio--ventricular conduction impairment.
    Giudicelli JF; Lhoste F; Boissier JR
    Eur J Pharmacol; 1975 Apr; 31(2):216-25. PubMed ID: 238853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation.
    Raeder EA; Verrier RL; Lown B
    J Am Coll Cardiol; 1983 Jun; 1(6):1442-6. PubMed ID: 6133890
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.
    Twum-Barima Y; Ahmad D; Hamilton JT; Carruthers SG
    Clin Pharmacol Ther; 1982 Sep; 32(3):289-94. PubMed ID: 6125288
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta-adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity.
    Louis WJ; McNeil JJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):317S-320S. PubMed ID: 6125183
    [No Abstract]   [Full Text] [Related]  

  • 72. Peripheral haemodynamic effects of beta-adrenoceptor blocking drugs with ISA or relative beta 1-selectivity at rest and during physical exercise.
    Rieckert H; Kattwinkel W; Riechelmann H; Kuss A; Sierau R
    Br J Clin Pharmacol; 1982; 13(Suppl 2):227S-228S. PubMed ID: 6125173
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior.
    Smith ER; Maurice J; Richardson R; Walter T; Davidson JM
    Pharmacol Biochem Behav; 1990 Aug; 36(4):713-7. PubMed ID: 1977175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of chronic beta-blockade on the ischaemic myocardium: a comparative study with five drugs.
    Manning AS; Hearse DJ; Coltart DJ
    J Cardiovasc Pharmacol; 1982; 4(6):999-1005. PubMed ID: 6185795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of beta-blocking agents on atrio-ventricular and intraventricular conduction in man.
    Chapelle M; Benaim R; Lejwi G
    Acta Cardiol; 1973; 28(3):238-54. PubMed ID: 4148108
    [No Abstract]   [Full Text] [Related]  

  • 76. Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in rats.
    Alexandre JM; Chevillard C
    Br J Pharmacol; 1980 May; 69(1):35-40. PubMed ID: 6103727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Specific and non-specific effects of beta-adreno-receptor blocking drugs in man (author's transl)].
    Grobecker H; Planz G; Wiethold G; Simrock R; Becker HJ; Lutz E; Petersen P
    Klin Wochenschr; 1976 Aug; 54(16):783-8. PubMed ID: 8664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.
    Cocco G; Burkart F; Chu D; Follath F
    Eur J Clin Pharmacol; 1978 Mar; 13(1):1-4. PubMed ID: 25186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
    Iwamura M; Ishimori T; Makino M; Yasuda K; Izumi A; Himori N
    Jpn J Pharmacol; 1983 Feb; 33(1):219-26. PubMed ID: 6135813
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.
    Botting JH; Crook P
    Experientia; 1981 Dec; 37(12):1320-2. PubMed ID: 6120090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.